glp 1 risk of cancer Does GLP-1 Increase Cancer? FDA Data and Safety Evidence Emerging Evidence Positions GLP-1 Receptor
Description
Proc Natl Acad Sci USA (1982) 79:3459
.png?w=1536&max-h=2752&fit=crop&auto=format)
Despite the cancer cases recorded with the use of semaglutide, other factors may have contributed to cancer development with no association with semaglutide [129]

Find out what happens if you have side effects, cannot obtain the medication, or do not see expected progress after several months

XM reviewed the paper and provided suggestions

Yes, refined sugar consumed on GLP-1 therapy often intensifies nausea because delayed gastric emptying combined with rapid glucose spikes creates gastrointestinal distress
However, growing awareness of the potential gallbladder risks associated with GLP-1 therapy has prompted clinicians to take a closer look at hepatobiliary safety
